Even though synthetic glucocorticoids, such as hydrocortisone and prednisolone, have been much used in the treatment of rheumatoid arthritis, their mode of action is not fully known. Attention has been paid to the possible beneficial effect of such steroids on lysosomes either in the inflammatory cells or in the cells of the synovial tissue because it is known that this type of steroid stabilizes the membranes of isolated lysosomes (Weissmann, 1968 (Weissmann, , 1969 . Bitensky et al. (1974) showed that a sufficient concentration of 10-4M glucocorticoids applied to synovial tissue maintained in vitro produced some stabilization of the lysosomal membranes in the synovial lining cells. Moreover they showed a quantitatively similar stabilization in vivo in patients who had been receiving at least 5 mg prednisolone a day; lower single daily doses of prednisolone had little or no effect. However, the maximum degree of stabilization achieved by even the higher concentrations of glucocorticoid was still only 30-50% of that found in the relatively normal synovial lining cells of nonrheumatoid joints.
It has also been observed (Butcher et al., 1973 ) that the activity of glucose 6-phosphate dehydrogenase in rheumatoid synoviocytes was three to four times greater than in the synoviocytes of nonrheumaAccepted for publication January 7, 1977 Correspondence to Dr. J. Chayen, Kennedy Institute of Rheumatology, Bute Gardens, Hammersmith, London W6 7DW toid synovial tissue. Because the hexose monophosphate pathway, and the reducing equivalents generated by it, subserve many functions in cellular metabolism, the raised activity ofglucose 6-phosphate dehydrogenase, the first step in this pathway, indicated a significant difference in the metabolic activity in the rheumatoid synoviocytes. Moreover there is evidence that cortisone, and steroids of similar configuration, influence the production and utilization of reducing equivalents generated by glucose 6-phosphate dehydrogenase activity . We therefore decided to investigate whether glucocorticoids affected this abnormally high rate of generation of NADPH, by glucose 6-phosphate dehydrogenase activity, in human synovial lining cells.
Material
The study was made on 13 specimens from 10 patients who had been treated either with nonsteroidal drugs or with <5 mg prednisolone/day; 8 specimens from 7 patients who had received 5 mg prednisolone or more each day; and 1 specimen from a patient treated with Acthar gel (Table 1 ). All had definite or classical rheumatoid arthritis according to the diagnostic criteria of the American Rheumatismi Association (Ropes et al., 1959) . The specimens were obtained at synovectomy. All patients who had been treated with prednisolone were given 100 mg Trowell (1959) maintenance culture for 20 hours (Poulter et al., 1970) . Various concentrations of glucocorticoids were added to the Trowell T8 medium used for maintaining some of these specimens. Where water-insoluble steroids were used, these were dissolved in absolute ethyl alcohol and added to the T8 medium to achieve a final concentration of alcohol of less than 1 %. In such cases an equivalent concentration of alcohol was included in the control. At the end of the culture period the specimens were chilled and stored in the same way as the biopsy specimens.
Methods
The tissue was sectioned at 12 ,tm in a Bright's cryostat with the cabinet temperature of -25°C and the knife cooled by having its haft packed with solid carbon dioxide. The sections were tested by the methods of Chayen et al. (1973a) for the following activities: (i) for glucose 6-phosphate dehydrogenase activity (total generation of NADPH), or (ii) for maximal oxidation of NADPH, or (iii) for the amount of NADPH, generated within the section by glucose 6-phosphate dehydrogenase activity, which was oxidized by the cells. For (i) the intermediate hydrogen-carrier phenazine methosulphate (PMS) was included in the reaction medium. Other studies have shown that this quantitative cytochemical method yields the same amount of dehydrogenase activity as the more conventional biochemical estimation (Altman, 1972) . For (ii) the substrate was exogenously added NADPH, while for (iii) it was glucose 6-phosphate and NADP+ with no intermediate hydrogen-carrier so that the reduction of the tetrazolium salt, by endogenously formed NADPH, depended solely on the microsomal respiratory pathway of the cells themselves (Chayen et al., 1973b) .
The reaction media contained 3 mg/ml of purified neotetrazolium chloride (Merck) in 0 05 M glycyl glycine buffer, pH 8 -0, containing 20 % w/v polyvinyl alcohol (PVA: B05/140; Wacker, Germany); 3 mM NADP+ and 5 mM glucose 6-phosphate disodium salt (Boehringer); for measuring the dehydrogenase activity the medium also contained 0-2 mg/ml PMS (Sigma). Before use, the medium was saturated with nitrogen and equilibrated to 37°C.
The end-product of these reactions was the highly coloured and precipitated formazan (reduced neotetrazolium chloride). This was measured in each of a number of synovial lining cells by means of a scanning and integrating microdensitometer.
Results

REPRODUCIBILITY OF MEASUREMENTS
Two specimens of synovial tissue were obtained from the joint in 5 subjects. The results (Table 2) give a measure of the sampling error which can occur between different parts of one synovial tissue. The mean value for all the readings from each specimen differed from the mean of all the readings (both specimens) by up to ± 190%, with three of the values differing by less than ±5 %. The reproducibility between serial sections taken from any one specimen was investigated in 8 specimens (Table 3) . The reproducibility was within ± 10 %; the standard error of the means of all readings was usually considerably better than this (as shown in Tables 4, 5, 6 ).
EFFECT OF GLUCOCORTICOIDS IN VITRO
In general the oxidative activities were well maintained after 20-hour maintenance culture (Table 4 ). In the nonrheumatoid tissue (Table 4) hydrocortisone at 10-4M concentration produced some depression of the glucose 6-phosphate dehydrogenase activity (tested with PMS). In specimen 1152, 10-6M hydrocortisone produced no change but an appreciable effect was found with 10-5 mol/l. This effect of 10-4M hydrocortisone on this activity in synovial lining cells from rheumatoid joints was much more marked (Table 4 ). Some depression of activity was observed even at 10-6 mol/l (specimen 1430). This depression of the dehydrogenase activity was mimicked to some extent by a small diminution in the rate of oxidation of the NADPH which was (Table 5) .
The difference in glucose 6-phosphate dehydrogenase activity in patients receiving at least 5 mg prednisolone a day, as against those receiving less than this dose (i.e. last column in Tables 5 and 6 respectively) was highly significant (P<0-001). 55-0±1-6 109+ 6.0 1373 6 mg/day prednisolone 20-5+0-6 20-0±0-7 
Discussion
The synovial lining cells of rheumatoid joints differ from those of nonrheumatoid joints in two cellular biochemical aspects. The first is that the lysosomal membranes of the former are considerably more permeable than the latter as tested by quantitative cytochemical methods . This pertains even when the synovium is taken from recently traumatized joints in whlch the lysosomal permeability, as assessed by this test, is greater than in more quiescent joints ). The second is that the maximal rate of production of NADPH, from NADP, is between 3 and 4 times greater in the rheumatoid than in the nonrheumatoid lining cells (Butcheretal., 1973) . It is well known that certain steroids, notably the glucocorticoids, may influence the permeability of membranes, particularly of lysosomes. Moreover, it has been shown that glucocorticoids administered in vivo exert some stabilizing influence on the lysosomes of the lining cells of the joints of rheumatoid patients treated with at least 5 mg glucocorticoid per day . However, even though there is good evidence that steroids can influence the activity of purified glucose 6-phosphate dehydrogenase (Marks and Banks, 1960; Levy et al., 1966) and activity of the enzyme in certain tissues , there has been no indication that glucocorticoids used in treating rheumatoid arthritis could influence this system. Our results show that the administration of glucocorticoids to rheumatoid patients is associated with a depression of glucose 6-phosphate dehydrogenase activity, provided that at least 5 mg prednisolone is given daily. At lower dosage the effect is indeterminate or not present. It must be borne in mind, however, that this threshold level may apply only to those joints with refractory disease since it is only these patients who come to synovectomy. For all that, it is of interest that Chamberlain and Keenan (1976) in a double-blind trial showed that patients receiving 3 mg prednisolone/day sustained little clinical benefit whereas some clinical improvement was apparent in those treated with 5 mg/day.
From the studies of Peterson and Wyngaarden (1956) it seems that steroids such as prednisolone become distributed throughout the extracellular body fluids. Consequently, taking the volume of these fluids as between 11 and 17 litres, 5 mg prednisolone would achieve a concentration outside the tissues of roughly 10-6 mol/l. It is noteworthy that in the studies on synovial tissue maintained in vitro (Table 4) hydrocortisone appreciably depressed glucose 6-phosphate dehydrogenase activity when the hydrocortisone was present at a concentration of 10-5 mol/l. The longer time that prednisolone would act in vivo might account for this ten-fold difference in concentration required to achieve the same effect in vitro as in vivo. Moreover, the duration of glucocorticoid concentration in the body may also influence the effect. Thus in the patient (Table 6 , specimen no. 1267) who received 3 mg prednisolone three times a day glucose 6-phosphate dehydrogenase activity was only 140 units of activity, whereas in the patient ( Table 5 . It may be noteworthy that treatment with Acthar gel (Table 6 , specimen no. 1339) produced the lowest activity recorded for any rheumatoid specimen. Perhaps the efficacy of glucocorticoid therapy in depressing the high glucose 6-phosphate dehydrogenase activity found in rheumatoid synovial lining cells depends (a) on the level achieved at any one time, and (b) on the duration of the daily exposure to raised levels of the steroid.
The implication of these findings is that, in unit time, rheumatoid synovial lining cells are capable of producing up to 4 times as many reducing equivalents, associated with glucose 6-phosphate dehydrogenase and NADP in the cytosol, as the non-rheumatoid cells. Yet their rate of oxidation of endogenously or exogenously added NADPH is reasonably similar. One effect of glucocorticoids is to diminish this rate of production of reducing equivalents. However, it is evident that even a dose of 6 mg/day does not depress the glucose 6-phosphate dehydrogenase activity to nonrheumatoid levels. 
